Pharmacological agents for developmental stuttering in children and adolescents: A systematic review

Journal of Clinical Psychopharmacology

Volumn 31, Issue 6, 2011, Pages 740-744

  Boyd, Alexander ^a   Dworzynski, Katharina ^b   Howell, Peter ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

developmental stuttering; persistent stuttering; recovered stuttering

Indexed keywords

ALPRAZOLAM; BETHANECHOL; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CLONIDINE; HALOPERIDOL; OLANZAPINE; OXPRENOLOL; PHENELZINE; PIMOZIDE; PLACEBO; PROPRANOLOL; RISPERIDONE; TIAPRIDE; VERAPAMIL;

CHILD DEVELOPMENT; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; COCHRANE LIBRARY; DEVELOPMENTAL DISORDER; DRUG EFFICACY; EMBASE; FOLLOW UP; HUMAN; MEDLINE; PRIORITY JOURNAL; PSYCINFO; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SCORING SYSTEM; SPEECH DISORDER; STUTTERING; SYSTEMATIC REVIEW;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; HUMANS; STUTTERING; TREATMENT OUTCOME;

EID: 80755163175     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318234ee3b     Document Type: Review

References (20)

1. Bothe AK, Davidow JH, Bramlett RE, et al. Stuttering treatment research 1970-2005: II. Systematic review incorporating trial quality assessment of pharmacological approaches. Am J Speech Lang Pathol. 2006;15;342-352.
2. Meline T, Harn WE. Comments on Bothe, Davidow, Bramlett, Franic, and Ingham (2006). Am J Speech Lang Pathol. 2008;17;93-97.
3. Andrews G, Harris M. The Syndrome of Stuttering. London, UK: Heinemann; 1964.
4. Yairi E, Ambrose NG. Early childhood stuttering: I. Persistency and recovery rates. J Speech Lang Hear Res. 1999;42;1097-1112. (Pubitemid 29463748)
5. Andrews G, Craig A, Feyer AM, et al. Stuttering: a review of research findings and theories circa 1982. J Speech Hear Disord. 1983;48;226-246. (Pubitemid 14235822)
6. Brady JP. The pharmacology of stuttering: a critical review. Am J Psychiatry. 1991;148;1309-1316.
7. Hackett J, Hoffman M, MacLeod A, et al. A study of the effects of chlorpromazine as an aid to therapy for stuttering with a one year follow-up. Paper presented at: the American Speech and Hearing Association Convention, New York, NY, 1958.
8. Burr HG, Mullendore JM. Recent investigations on tranquilizers and stuttering. J Speech Hear Disord. 1960;25;33-37.
9. Lavid N, Franklin DL, Maguire GA. Management of child and adolescent stuttering with olanzapine: three case reports. Ann Clin Psychiatry. 1999;11;233-236.
10. Van Wattum PJ. Stuttering improved with risperidone. J Am Acad Child Adolesc Psychiatry. 2006;45;133. (Pubitemid 43151516)
11. Rotherberger A, Johanssen HS, Schulze H, et al. Use of tiapride on stuttering in children and adolescents. Percept Mot Skills. 1994;79;1163-1170.
12. Tapia F. Haldol in the treatment of children with tics and stutterers and an incidental finding. Behav Neuropsychiatry. 1969;1;28.
13. Vink HJ, Althaus M, Goorhuis-Brouwer SM, et al. Clonidine and stuttering. Am J Psychiatry. 1992;149;717-718.
14. Althaus M, Vink HJ, Minderaa RB, et al. Lack of effect of clonidine on stuttering in children. Am J Psychiatry. 1995;152;1087-1089.
15. Joint-Formulary-Committee. British National Formulary 59. London, NY: Pharmaceutical Press; 2010.
16. Paediatric-Formulary-Committee. British National Formulary for Children. London, UK: Pharmaceutical Press; 2009.
17. Wingate M. Foundations of Stuttering. San Diego, CA: Academic Press; 1975.
18. Maguire G, Frankin D, Vatakis NG, et al. Exploratory randomized clinical study of pagoclone in persistent developmental stuttering: the EXamining Pagoclone for peRsistent dEvelopmental Stuttering Study. J Clin Psychopharmacol. 2010;30;48-56.
19. Alm PA. Stuttering and the basal ganglia circuits: a critical review of possible relations. J Commun Disord. 2004;7;325-369. (Pubitemid 38680901)
20. Fisher SE. Genetic susceptibility to stuttering. N Engl J Med. 2010;362;750-752.